Key facts
- MedVector’s last known valuation is $11.0M (Jul 2021).
- It has raised $5.1M across 3 recorded rounds; the latest was Seed Round ($1.0M) in Oct 2025.
- MedVector has filed 2 Form Ds with the SEC since 2022, most recently Nov 2023 ($700K sold to 7 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 3 rounds
- ·Watchlist + deal alerts for MedVector
Funding rounds
3 roundsAbout MedVector
Operator of a healthcare technology intended to facilitate observational connectivity. The company's technology enables HCP Recruitment for clinical trials by unlocking access to patients trapped behind non-participating physicians and unapproved locations as well as offers a combination device, platform, and patient network used to identify and connect patients to existing clinical trial sites, enabling investigators access to more diverse patients, physicians access to clinical trials as a care option, and health equity of advanced medicine from inner-city and rural locations regardless of socioeconomic status.
- Sector
- Healthcare
- HQ
- El Segundo, CA, United States
- Founded
- 2017
- Employees
- 12
- Website
- medvector.com/
- Ownership
- Privately Held (backing)
MedVector doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MedVector shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MedVector in its N-PORT filings yet. We sweep new filings monthly.